News

226 to 235 of 96126 results

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Roche makes another acquisition, paying $8.3 billion for InterMune

Roche makes another acquisition, paying $8.3 billion for InterMune

25-08-2014

Announcing its fourth acquisition this year, Swiss pharma major Roche said on Sunday that it has entered…

EsbrietInterMuneMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoche

US Administration to ensure women’s continued access to contraception coverage, while respecting religious-based objections

US Administration to ensure women’s continued access to contraception coverage, while respecting religious-based objections

25-08-2014

On Friday, the Obama Administration in the USA took several steps to help ensure women, whose coverage…

FinancialPharmaceuticalRegulationReproductiveUSA

ViiV Healthcare gains FDA approval for HIV drug Triumeq

ViiV Healthcare gains FDA approval for HIV drug Triumeq

23-08-2014

The US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine…

Anti-viralsGlaxoSmithKlinePfizerPharmaceuticalRegulationShionogiTriumeqUSAViiV Healthcare

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

23-08-2014

Pershing Square Capital Management, the largest shareholder of Allergan, which is the subject of a $53…

AllerganManagementMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Actavis confirms patent challenge for generic Neupro

Actavis confirms patent challenge for generic Neupro

23-08-2014

Ireland-headquartered generics major Actavis on Friday confirmed that it has filed an Abbreviated New…

ActavisGenericsLegalNeuproNeurologicalPatentsRegulationUCBUSA

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

23-08-2014

Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being…

Anti-viralsHera Therapeuticshti-1968PharmaceuticalResearchWomen's Health

Cubist's ceftolozane/ tazobactam accepted for Marketing Authorization Application review by EMA

Cubist's ceftolozane/ tazobactam accepted for Marketing Authorization Application review by EMA

22-08-2014

The European Medicines Agency has accepted for review a Marketing Authorization Application by American…

Antibiotics and Infectious diseasesceftolozaneComplicated intra-abdominal infectionsComplicated urinary tract infectionsCubist PharmaceuticalsEnterobacteriaEuropean Medicines AgencyGram-negative bacteriaPharmaceuticalRegulationtazobactamUSA

ViaCyte gets $20 million in deal with Janssen

ViaCyte gets $20 million in deal with Janssen

22-08-2014

Privately held US regenerative medicine company ViaCyte has entered into a rights agreement with Janssen…

BiotechnologyDiabetesEndocrine systemFinancialJanssenJohnson & JohnsonLicensingUSAVC-01ViaCyte

226 to 235 of 96126 results

Back to top